Oxaliplatin (SR96669)

DRUG5 trials

Conditions

Colonic NeoplasmsColorectal NeoplasmsGastric CancerGastrointestinal CancerHepatic Neoplasm Malignant

Phase 2

Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function

CompletedNCT00094965

SanofiGastrointestinal Cancer

Start: 2004-09-30End: 2007-08-31Updated: 2009-03-30

Colorectal Cancer RECHALLENGE

WithdrawnNCT00988897

SanofiColorectal Neoplasms

Start: 2009-10-31End: 2012-05-31Updated: 2009-12-23

Phase 3

MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer

CompletedNCT00275210

SanofiColonic Neoplasms

Start: 1998-10-31End: 2003-04-30Updated: 2009-04-20

Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients

WithdrawnNCT01245582

SanofiHepatic Neoplasm Malignant

Start: 2011-07-31End: 2015-08-31Updated: 2011-11-09

Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer

CompletedNCT01515748

SanofiGastric Cancer

Start: 2011-12-30End: 2021-12-13Updated: 2023-12-13

UNC Libraries2024-01-31

Neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 for resectable advanced gastric cancer: Final survival outcomes of the randomized phase 3 PRODIGY trial.

JCO Global Oncology2023-08-011 citations

Neoadjuvant docetaxel, oxaliplatin, and s-1 plus surgery and adjuvant s-1 for resectable advanced gastric cancer: Final survival outcomes of the randomized phase 3 PRODIGY trial.

Journal of Clinical Oncology2023-06-0114 citations

Comparing Trial and Real-world Adjuvant Oxaliplatin Delivery in Patients With Stage III Colon Cancer Using a Longitudinal Cumulative Dose

JAMA Oncology2022-10-135 citations

Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial

Contemporary Clinical Trials Communications2021-11-091 citations

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer

Journal of Clinical Oncology2021-06-16327 citations

Locally advanced rectal adenocarcinoma: Treatment sequences, intensification, and rectal organ preservation

CA A Cancer Journal for Clinicians2021-02-1621 citations

Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database.

2020-01-1625 citations

Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial

British Journal of Cancer2019-07-1121 citations

A randomized phase III study of neoadjuvant chemotherapy with docetaxel(D), oxaliplatin(O), and S-1(S) (DOS) followed by surgery and adjuvant S-1 vs. surgery and adjuvant S-1 for resectable advanced gastric cancer (PRODIGY).

Journal of Clinical Oncology2015-05-207 citations

Oxaliplatin (SR96669)

Sponsors

Conditions

Phase 2

Phase 3

Related Papers